Drug Discovery and Development

BD debuts compact flow cytometry cell analyzer

The new system supports a range of flow cytometry experiments.

By |

BD FAC Symphony A1Flow cytometry is a powerful technology given its ability to analyze the physical and chemical properties of cells and particles.

But many laboratories struggle to find space for advanced flow cytometry cell analyzers.

BD (NYSE:BDX) has responded to that challenge with its benchtop FACSymphony A1 cell analyzer.

BD designed the fluorescence-activated cell analyzer to support modern research demands in a small footprint.

The analyzer can precisely isolate single cells from complex samples. It supports small particle research as well as 16-color immunophenotyping.

The FACSymphony A1 “offers high-end technology and a cost-effective benchtop design,” surmised Thomas E. Polen, BD CEO, in a recent earnings calls.

The FACSymphony A1 cell analyzer supports various types of flow cytometry experiments. In addition, an optional small particle detector enables the analysis of extracellular vesicles.

BD recently debuted its spectral analyzer as well, which is known as the FACSymphony A5 SE.

Filed Under: Drug Discovery and Development, R&D World, RD
Tagged With: , , , , , ,
 

About The Author

Brian Buntz

As the pharma and biotech editor at WTWH Media, Brian has almost two decades of experience in B2B media, with a focus on healthcare and technology. While he has long maintained a keen interest in AI, more recently Brian has made making data analysis a central focus, and is exploring tools ranging from NLP and clustering to predictive analytics.

Throughout his 18-year tenure, Brian has covered an array of life science topics, including clinical trials, medical devices, and drug discovery and development. Prior to WTWH, he held the title of content director at Informa, where he focused on topics such as connected devices, cybersecurity, AI and Industry 4.0. A dedicated decade at UBM saw Brian providing in-depth coverage of the medical device sector. Engage with Brian on LinkedIn or drop him an email at bbuntz@wtwhmedia.com.

Related Articles Read More >

Search Drug Discovery & Development